Introduction
An important aspect of cell functioning is the ability to regulate gene expression in response to environmental changes. One of the most common ways of altering gene expression is by modulating the rate of transcriptional initiation. Typically, an environmental signal such as a hormone reaches the cell surface and triggers a series of intracellular signal transduction events that result ultimately in either activation or inactivation of a sequence-specific DNA-binding transcription factor within the nucleus. In many cases, the change in transcription factor activity is achieved via phosphorylation [ 1, 2] . Important features of phosphorylation are its potenAbbreviation used: DNA-PK, DNA-dependent protein kinase. tial rapidity and reversibility, which allow cells to make speedy responses to environmental stimuli. Another advantage of phosphorylation as a regulatory mechanism is that a single transcription factor can be targeted by more than one kinase, thus providing an effective means of integrating information from a variety of signal transduction pathways.
Although much is known about the structure and function of transcription factors, relatively little is understood about the kinases that affect their activity. In the cell, it is clear that most physiologically relevant transcription factor kinases must reside within the nuclear compartment. Furthermore, for many of these kinases to access their substrates, it is likely that they themselves will have to become associated with the transcriptional machinery assembled on DNA. One kinase that Volume 21 appears well-suited to a role in modulating transcription factor activity is the DNA-dependent protein kinase (DNA-PK). This enzyme is unusual in that it is a DNA-binding protein and, in fact, needs to be bound to DNA to be active [3-71. This paper summarizes recent research directed towards trying to understand the structure, function and potential regulation of this enzyme.
DNA-PK phosphorylates transcription factors
DNA-PK was identified originally as a DNAdependent activity in mammalian cell extracts that modified hsp9O [8] . It was not until several years later, however, that DNA-PK was shown to phosphorylate nuclear DNA-binding proteins. Our work showed that the human transcription factor Spl is rapidly and multiply phosphorylated by DNA-PK in vitro in a DNA-dependent manner [5] . Interestingly, we found that Spl-binding-site motifs (GC boxes) must be present on the DNA for efficient phosphorylation to occur, indicating that DNAbound Spl is the preferred substrate. Furthermore, DNA competition studies revealed that DNA-PK must be bound in cis on the same DNA molecule as Spl for effective Spl phosphorylation [9] . We and others have subsequently shown that DNA-PK can phosphorylate a variety of other DNA binding proteins, including the simian virus 40 virus large T-antigen, CCAAT-binding transcription factor-1, c-jun, murine p53, and c-myc [3, 5, 7, 10-131. Although a physiological role for DNA-PK has yet to be determined, it has been proposed that DNA-PK might activate transcription factors, and that DNA-PK-mediated phosphorylation is a mechanism to generate active transcription factors only when they are positioned on transcriptional promoters ( Figure 1) [5].
Molecular composition of DNA-PK
Whilst determining where on the DNA molecule DNA-PK binds in relation to Spl, we made the surprising discovery that it binds to the ends of linear DNA molecules [9] . Furthermore, we found that DNA termini are required for DNA-PK activity in vitro. The unusual DNA-end-binding mode is demonstrated both with purified DNA-PK and with crude nuclear extracts containing DNA-PK. Although it is possible that DNA-end binding is an artefact of the in vitro assay, it is tempting to speculate that DNA ends serve as DNA-PK cofactors in viva We are examining the possibility, therefore, that DNA-PK is activated within the cell in response to DNA damage, or by DNA replication intermediates that bear DNA termini (T. Gottlieb and S. P. Jackson, unpublished work [26] [27] [28] . When we compared the nucleic-acid binding properties of Ku and of DNA-PK, we found them to be identical [9] . This, together with the fact that Ku was known to copurify with DNA-PK [3], prompted us to test for a possible involvement of Ku in DNA-PK function. Through biochemical fractionation, we established that DNA-PK activity requires two essential components [9] . One of these components specifies DNA binding and corresponds to Ku, since this activity copurifies with Ku, is recognized by anti-Ku antisera and can be substituted by purified Ku (Figure 2 ) [9] . The other DNA-PK component possesses the kinase catalytic site and corresponds to a polypeptide of approximately 350 kDa (p350). Similar conclusions have been drawn by Dynan and colleagues, who have fractionated DNA-PK into Ku and p350 components [29, 30] .
Although DNA-PK requires DNA termini, we have found that Spl can be bound several kb from the nearest DNA end and yet still be phosphory- proteinases, resolve resulting peptides and then
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Ku is a component of DNA-PK Spl phosphorylation assays were conducted as described pre-
In outline, unphosphorylated [3Y]Sp I was incubated at 30°C for 7 min with ATP in the presence of various protein fractions, then analysed by SDYPAGE, followed by autoradiography Phosphorylated and unphosphorylated Sp I (Sp I -P and Spl respectively) are differentiated readily by their different gel mobilities The two Ku protein preparations used were approx 95% pure and were kindly provided by Mark Knuth The p350 fraction lacks Ku and was generated by single-stranded DNA-cellulose fractionation of a HeLa nuclear extract as described previously [9] p350: / l A A
-- lated efficiently [9] . There are two possible mechanisms by which DNA-PK accesses distal Spl molecules. In one, the kinase remains attached to the DNA end but makes contact with Spl through the looping out of the intervening DNA. In the other, DNA-PK binds to a DNA end and then slides along the molecule to reach Spl. 
Regulation of DNA-PK activity

Identification of the DNA-PK phosphorylation recognition sequence
One approach to reveal the consequences of DNA-PK-mediated phosphorylation is to define sites of modification on target proteins and then determine the effect of mutating these sites on target protein function. In recent years, it has become clear that many protein kinases recognize specific amino acid sequences in their substrates; usually, these consist of the phosphorylated residue itself and a few flanking residues. Work in our laboratory has shown that this is also the case for DNA-PK [31] . The approach we took was to express in bacteria wild- [7] . We conclude, therefore, that the optimal phosphorylation by DNA-PK requires the sequence Ser/Thr-Gln in a protein region of non-basic character.
In the cell, of course, other factors as well as primary protein sequence will play a crucial role in determining whether a protein is a DNA-PK substrate. Most importantly, in vivo, only nuclear DNA-binding proteins are likely to be accessed by DNA-PK. In addition, the conformation of the target protein or interactions with other molecules may mask potential DNA-PK phosphorylation sites. Notwithstanding these caveats, the definition of the DNA-PK recognition sequence should help to identify sites of phosphorylation in other proteins. Interestingly, analysis of the Spl sequence reveals 14 Ser/Thr-Gln motifs. Strikingly, none resides in the C-terminal region that contains the DNA-binding domain. Consistent with this, we have found that phosphorylation by DNA-PK has no apparent effect on DNA binding by Spl, and that the C-terminal region of Spl is not phosphorylated efficiently in vivo (T. Gottlieb and S. P. Jackson, unpublished work) [ 51. The N-terminal portion of Spl consists of two activation domains that are rich in glutamine residues, and two regions rich in serine and threonine residues [ 3 5 ] . Of the 14 potential DNA-PK phosphorylation sites, ten lie in the Ser/Thr-rich regions of Spl, while four lie within the Gln-rich regions.
To see whether a Ser/Thr-rich region of Spl can indeed be phosphorylated by DNA-PK, we expressed one of these in Escherichia coli fused to the DNA-binding domain of Saccharomyces cerevkiae GAL4. This protein was then purified and tested for phosphorylation by DNA-PK. These analyses showed that this protein is phosphorylated much more efficiently than unfused GAL4, and that efficient phosphorylation requires the GAL4 DNAbinding consensus sequences (Figure 3 a) . These data therefore suggest that searching for protein
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Figure 3 DNA-PK phosphorylates transcription factors in vitro that bear Ser/Thr-Gln motifs ( a ) Equal quantities of three purified recombinant proteins were tested for DNA-PK mediated phosphorylation: S. cerevisiae GAL4 DNA binding domain (residues 1-147) alone (lanes 1-3); GAL4 fused t o a Ser/Thr-rich region (residues 22-140) of Spl (lanes 4-6): GAL4 fused to residues 1-73 of human p53 (lanes 7-9). Proteins were incubated at 30°C for 7 min with [32P]ATP in the presence of purified DNA-PK and then detected by SDYPAGE followed by fluorography. Reactions were performed in the absence of DNA (lanes I , 4 and 7), or in the presence of linearized plasmid DNA lacking GAL4-binding sites (lanes 2, 5 and 8), or containing GAL4-binding sites (lanes 3, 6 and 9). ( b ) Recombinant human Mdm-2 protein was generated in E. coli using an expression plasmid kindly provided by A. Levine, purified and tested for phosphorylation by DNA-PK as described in (a). regions bearing Ser/Thr-Gln sequences will, indeed, be useful in identifying sites of DNA-PK phosphorylation. By expressing smaller portions of Spl linked to GAL4 and, subsequently, by point mutagenesis of this region, it should be possible to map the precise sites of DNA-PK phosphorylation in Spl.
Identifying other DNA-PK substrates
Sequence analysis reveals that Ser/Thr-Gln motifs are also present in many other transcription factors. Interestingly, in a great many cases, these occur in clusters in the protein primary sequence, rather than as scattered single sites. Furthermore, as is the case with c-Jun, they often occur in regions that are phosphorylated by other kinases. Potential DNA-PK substrates identified this way include E2F, serum response factor, cyclic-AMP-responsiveelement binding protein, activating transcription factor-1, MyoD, the Wilm's tumour suppressor protein (WT-1) and several nuclear hormone receptors. When we assayed E2F and serum response factor, we found that both are indeed phosphorylated by DNA-PK (T. Gottlieb, R. Marais, R. Treisman and S. P. Jackson, unpublished work). We predict that many other transcription factors that bear Ser/Thr-Gln motifs will serve as DNA-PK substrates. Another protein that contains multiple Ser/ Thr-Gln motifs is the p5 3 anti-oncogene product. Although the precise role of p53 has yet to be determined, recent work has indicated that it is a transcription factor and is involved in mediating responses to DNA damage [ 361. Given our findings that DNA-PK activity in vitro requires DNA breaks, we are keen to establish whether it is a regulator of p53 activity. Interestingly, the Ser/Thr-Gln motifs in p53 occur in the N-terminal portion of the protein that serves as a transcription activation domain. T o test whether this region of p53 is phosphorylated by DNA-PK, we expressed the Nterminal 73 amino acid residues of p53 in E. coli fused to the DNA-binding domain of yeast GAL4.
Incubation of this chimera with DNA-PK in vitro revealed that it is phosphorylated in a DNAdependent reaction that is stimulated by GAL4-binding sites (Figure 3a) . Furthermore, we have found that full-length p53 protein, kindly provided by D. Lane, is also phosphorylated (N. Finnie and S. P. Jackson, unpublished work). These findings are consistent with recent reports that have shown p53 to be phosphorylated in vitro by DNA-PK [ 12, 131.
A molecule that has received much attention recently in p53 research is the protein product of the mdm-2 cellular oncogene, since it binds to the N-terminal activation domain of p53 and represses transcriptional activation by p53 in vivo [37, 381. We were intrigued, therefore, by the fact that Mdm-2 was pulled out in a computer database for proteins bearing multiple clustered Ser/Thr-Gln motifs. As can be seen from Figure 3(b) , we have found that purified recombinant Mdm-2 is an efficient DNA-PK substrate in vitro. Obviously, it will now be of great interest to see whether the transcriptional activation by p53, the repression of p53 activity by Mdm-2 or the interaction between these two proteins is affected by DNA-PK phosphorylation.
We thank Mark Knuth for providing purified Ku and Arnold Levine for the Mdm-2 expression vector. We also thank Ruth Dendy for help with preparing this paper. N.F. is a recipient of an MRC studentship. Work in the S.P.J. laboratory is supported by Programme Grant number SP2143/0101 from the Cancer Research Campaign.
Introduction
The DNA tumour viruses including adenovirus, polyomavirus/simian virus 40 (SV40) and the human papillomavirus possess the capacity to transform cells oncogenically in culture [ 11, and indeed the papillomaviruses represent an important causative agent for human cervical carcinoma [Z] .
Nevertheless, the oncogenic properties of the DNA tumour viruses are actually a byproduct of a nonproductive lytic infection. The normal goal of these viruses is to replicate and produce new virus. Moreover, the activities that are involved in the oncogenic capacity of theses viruses must function normally to facilitate lytic growth. Indeed, it would appear that it is the strategy that these viruses have developed to achieve a replicative cycle in a quiescent cell that probably also results in oncogenic transformation when a lytic infection cannot proceed. Recent events have revealed details of these mechanisms, including the ability of these viruses to Abbreviations used: Rb. retinoblastoma; SV40, simian virus 40.
inactivate key regulatory proteins involved in cellgrowth control. Most importantly, an understanding of these events in the context of the lytic infection has shed light on the manner by which these viruses can cause oncogenic transformation and cancer.
Disruption of E2F regulation by the DNA tumour viruses
One strategy that was directed at the identification of targets for the action of the adenovirus E1A protein involved the analysis of proteins in physical association with E 1A as judged by co-immunoprecipitation. These studies revealed a series of cellular proteins in physical association with E1A [ 3 , 41. Although originally identified as a series of bands in SDS/polyacrylamide gels (see Figure 1 a) , subsequent analyses demonstrated that one of these E 1A-associated proteins, a protein of 105 kDa, was the product of the retinoblastoma (Rb) tumour suppressor gene [5] . This finding was of great importance in focusing attention on the relationship between the action of a viral oncoprotein with a
